BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

697 related articles for article (PubMed ID: 9058806)

  • 41. Uptake of microparticle-adsorbed protein antigen by bone marrow-derived dendritic cells results in up-regulation of interleukin-1 alpha and interleukin-12 p40/p35 and triggers prolonged, efficient antigen presentation.
    Scheicher C; Mehlig M; Dienes HP; Reske K
    Eur J Immunol; 1995 Jun; 25(6):1566-72. PubMed ID: 7614984
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phosphatidylserine receptor-mediated recognition of archaeosome adjuvant promotes endocytosis and MHC class I cross-presentation of the entrapped antigen by phagosome-to-cytosol transport and classical processing.
    Gurnani K; Kennedy J; Sad S; Sprott GD; Krishnan L
    J Immunol; 2004 Jul; 173(1):566-78. PubMed ID: 15210818
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficient scavenger receptor-mediated uptake and cross-presentation of negatively charged soluble antigens by dendritic cells.
    Shakushiro K; Yamasaki Y; Nishikawa M; Takakura Y
    Immunology; 2004 Jun; 112(2):211-8. PubMed ID: 15147564
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MHC class I-restricted presentation of exogenous antigen by thymic antigen-presenting cells in vitro and in vivo.
    Grant EP; Rock KL
    J Immunol; 1992 Jan; 148(1):13-8. PubMed ID: 1727862
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Weak base amines can inhibit class I MHC-restricted antigen presentation.
    Michalek MT; Benacerraf B; Rock KL
    J Immunol; 1991 Jan; 146(2):449-56. PubMed ID: 1987272
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Introduction of exogenous antigens into the MHC class I processing and presentation pathway by Drosophila antennapedia homeodomain primes cytotoxic T cells in vivo.
    Schutze-Redelmeier MP; Gournier H; Garcia-Pons F; Moussa M; Joliot AH; Volovitch M; Prochiantz A; Lemonnier FA
    J Immunol; 1996 Jul; 157(2):650-5. PubMed ID: 8752913
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains.
    Machy P; Serre K; Baillet M; Leserman L
    J Immunol; 2002 Feb; 168(3):1172-80. PubMed ID: 11801652
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Electroporation of exogenous antigen into the cytosol for antigen processing and class I major histocompatibility complex (MHC) presentation: weak base amines and hypothermia (18 degrees C) inhibit the class I MHC processing pathway.
    Harding CV
    Eur J Immunol; 1992 Jul; 22(7):1865-9. PubMed ID: 1623927
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Macrophage presentation of endogenous self-protein: the MHC class II presentation pathway is not accessible to intracellular C5 or alpha 1-antitrypsin.
    Grant CF; Ali R; Povey S; Stockinger B
    Cell Immunol; 1996 Feb; 167(2):230-40. PubMed ID: 8603432
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells.
    Pfeifer JD; Wick MJ; Roberts RL; Findlay K; Normark SJ; Harding CV
    Nature; 1993 Jan; 361(6410):359-62. PubMed ID: 7678924
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells.
    Guermonprez P; Saveanu L; Kleijmeer M; Davoust J; Van Endert P; Amigorena S
    Nature; 2003 Sep; 425(6956):397-402. PubMed ID: 14508489
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition by brefeldin A of the specific B cell antigen presentation to MHC class II-restricted T cells.
    Kakiuchi T; Takatsuki A; Watanabe M; Nariuchi H
    J Immunol; 1991 Nov; 147(10):3289-95. PubMed ID: 1940337
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Viral and bacterial minigene products are presented by MHC class I molecules with similar efficiencies.
    Wolf BJ; Princiotta MF
    Mol Immunol; 2011 Jan; 48(4):463-71. PubMed ID: 21067810
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Presentation of Leishmania donovani promastigotes occurs via a brefeldin A-sensitive pathway.
    Lang T; Kaye PM
    Eur J Immunol; 1991 Oct; 21(10):2407-13. PubMed ID: 1680697
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation.
    Delamarre L; Holcombe H; Mellman I
    J Exp Med; 2003 Jul; 198(1):111-22. PubMed ID: 12835477
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Roles of proteasomes, transporter for antigen presentation (TAP), and beta 2-microglobulin in the processing of bacterial or particulate antigens via an alternate class I MHC processing pathway.
    Song R; Harding CV
    J Immunol; 1996 Jun; 156(11):4182-90. PubMed ID: 8666786
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chemical denaturation and modification of ovalbumin alters its dependence on ubiquitin conjugation for class I antigen presentation.
    Michalek MT; Grant EP; Rock KL
    J Immunol; 1996 Jul; 157(2):617-24. PubMed ID: 8752909
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficient presentation of both cytosolic and endogenous transmembrane protein antigens on MHC class II is dependent on cytoplasmic proteolysis.
    Mukherjee P; Dani A; Bhatia S; Singh N; Rudensky AY; George A; Bal V; Mayor S; Rath S
    J Immunol; 2001 Sep; 167(5):2632-41. PubMed ID: 11509605
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Classical MHC class I peptide presentation of a bacterial fusion protein by bone marrow-derived dendritic cells.
    Svensson M; Wick MJ
    Eur J Immunol; 1999 Jan; 29(1):180-8. PubMed ID: 9933099
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bacterial heat shock proteins promote CD91-dependent class I MHC cross-presentation of chaperoned peptide to CD8+ T cells by cytosolic mechanisms in dendritic cells versus vacuolar mechanisms in macrophages.
    Tobian AA; Canaday DH; Boom WH; Harding CV
    J Immunol; 2004 May; 172(9):5277-86. PubMed ID: 15100266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.